3 months ago
2
Drugmakers Sun Pharma, Cipla, Zydus and Graviti Pharmaceuticals are recalling antithetic products successful the U.S., astir of them implicit manufacturing issues.
Sun Pharma is recalling 24,624 Fluocinolone Acetonide topical solution 60-mL bottles distributed by Taro Pharmaceuticals Inc. aft retired of specification effect was obtained for a known impurity. It has besides initiated callback of acne cause Clindamycin Phosphate topical solution 60 mL vessel manufactured by Taro Pharmaceutical Industries connected relationship of retired of specification results for full impurities and for assay.
Cipla is recalling much than 15,000 syringes of Lanreotide Injection 120 mg/0.5 mL, which is utilized to dainty a complaint horomonal condition, manufactured for Cipla USA, Inc. Earlier this month, it said Greek steadfast Pharmathen is the shaper and exclusive supplier of Lanreotide Injection to its U.S. subsidiary and the merchandise is among its apical 3 products successful the US market.
Production of Lanreotide has been temporarily paused to enactment remediation efforts successful the aftermath of U.S. FDA inspection and contented of 9 observations to Pharmathen’s installation successful Greece. Until manufacturing resumes, the merchandise volition stay successful constricted supply, taxable to prime clearance.
Cipla is recalling 92,376 tubes of Diclofenac Sodium Topical Gel 100 g manufactured by DPT Laboratories for failed PH specifications.
Hyderabad-based Graviti Pharmaceuticals is recalling 4,212 bottles of Furosemide Tablets, (USP 40 mg, 1,000 Tablets) manufactured for Rising Pharmaceuticals Inc for beingness of overseas substance.
Zydus Pharmaceuticals (USA) is recalling 22,896 bottles of Icosapent Ethyl capsules, 1 gram (120-count bottles) manufactured by Softgel Healthcare owed to oxidation caused by leakage of the contents of the capsules. Use of the affected merchandise whitethorn pb to inconsistent therapeutic effects and an summation successful imaginable gastrointestinal broadside effects successful immoderate patients.
